Last reviewed · How we verify

COVID-19 — Treatment Landscape & Competitive Intelligence

COVID-19 (Infectious Disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Infectious Disease 10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating COVID-19, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Paxlovid (Copackaged) Nirmatrelvir Pfizer Antiviral protease inhibitor SARS-CoV-2 main protease (Mpro, 3CLpro, nsp5 protease) 2023-01-01
Regkirona REGDANVIMAB Celltrion Healthcare Hungary Kft. 2021-01-01
Ronapreve CASIRIVIMAB Regeneron Pharmaceuticals, Inc. 2020-01-01
Ly-Cov016 ETESEVIMAB Eli Lilly and Company 2020-01-01
Norvir ritonavir AbbVie Cytochrome P450 3A Inhibitor [EPC] Cytochrome P450 2C9 1996-01-01
CILGAVIMAB CILGAVIMAB AstraZeneca
Evusheld TIXAGEVIMAB AstraZeneca
Vaccine Support Cp Vaccine administration Women and Infants Hospital of Rhode Island vaccine unknown
ibuzatrelvir ibuzatrelvir Pfizer Antiviral SARS-CoV-2 main protease (Mpro)
Low Dose PF-07328948 low-dose-pf-07328948 Pfizer small molecule SARS-CoV-2 virus

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Pfizer · 9 drugs in COVID-19
  2. Eli Lilly and Company · 2 drugs in COVID-19
  3. Regeneron Pharmaceuticals, Inc. · 2 drugs in COVID-19
  4. AstraZeneca · 2 drugs in COVID-19
  5. Saint Michael's Medical Center · 1 drug in COVID-19
  6. AbbVie · 1 drug in COVID-19
  7. Women and Infants Hospital of Rhode Island · 1 drug in COVID-19
  8. Celltrion Healthcare Hungary Kft. · 1 drug in COVID-19
  9. Msd K.K. · 1 drug in COVID-19
  10. Pfizer Inc. · 1 drug in COVID-19

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in COVID-19:

Cite this brief

Drug Landscape (2026). COVID-19 — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/covid-19. Accessed 2026-05-13.

Related